RNS Number : 9595M
Meldex International PLC
06 February 2009
For Immediate Release 6 February 2009
Meldex International Plc ("Meldex " or "the Company")
Review Update
Cambridge, UK, 6 February, 2009: Meldex International Plc (AIM: MDX), the directors report the following progress on their review of the Company's business activities.
Appointment of NOMAD
The directors are in discussions with potential NOMADs with a view to an appointment on or prior to 16 February 2009. However, there can be no assurance that such an appointment will be made on time or at all.
Ostomy Patent
On appeal by Hollister at a hearing of the Appeal Board of the European Patent Office, at which the Company made no representation, the Company's Patent No 0 833 596 was revoked. The decision of the Appeal Board is final and no further appeal is permitted, therefore the Company will take no further action in the matter. Prior to the appeal being held the Company's former Chairman made the decision not to be represented at the appeal hearing.
Melbrosin GmbH
The Company is the largest creditor of Melbrosin GmbH and a claim is being prepared for submission to the Administrators, this claim will be submitted early in March 2009 as requested by the Administrators.
Melbrosin Austria
The Company has requested the directors of Melbrosin Austria to apply for an administrator to be appointed. An initial meeting with a potential administrator has been held and an application submitted to the relevant authority.
Development Programme
The directors have met with an independent specialist pharmaceutical company with a view to having certain of its portfolio of Rx and OTC dossiers reviewed for commercial potential. The Company will report the results of this exercise when received.
A further update will be made on or before 13 February 2009.
For information contact:
Gary Cressman +44 (0) 1223 394 250
Meldex International plc
Barry Muncaster +44 (0) 1223 394 250
Meldex International plc
BJM@meldexinternational.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCSSMFIMSUSEIE
